Saitama, Japan

Masaru Motojima

This inventor holds 1 USPTO granted patent. Top assignee: Kureha Chemical Industry Company, Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Motojima. Retrieved from https://idiyas.com/inventor/masaru-motojima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaru Motojima: Innovator in Oligonucleotide Research

Introduction

Masaru Motojima is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide inhibitors.

Latest Patents

One of his notable patents is titled "Oligonucleotides inhibitors of PAI-1 mRNA." This patent discloses an oligonucleotide containing a sequence of SEQ ID NO: 1: CAGTGAGTGG GTGGGGCTGG AACA, or SEQ ID NO: 2: TTAAGCTTTT ACCATGGTAA CCCC. It also includes a pharmaceutical composition comprising the oligonucleotide and a method for treating or preventing diseases accompanied by extracellular matrix deposition. This innovation highlights the potential therapeutic applications of oligonucleotides in medical science.

Career Highlights

Masaru Motojima is associated with Kureha Chemical Industry Company, Limited, where he continues to advance his research and development efforts. His work has garnered attention for its implications in treating various medical conditions.

Collaborations

He collaborates with Takao Ando, contributing to the innovative research environment at Kureha Chemical Industry Company.

Conclusion

Masaru Motojima's contributions to oligonucleotide research exemplify the intersection of innovation and biotechnology. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…